$5.63 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 143 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 48.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTRS | Buy | VIATRIS INC | $268,995,000 | +11.8% | 18,824,000 | +9.3% | 4.78% | -5.5% |
| OMIC | New | SINGULAR GENOMICS SYSTEMS IN | $250,398,000 | – | 9,112,019 | +100.0% | 4.45% | – |
| INVITAE CORPnote 2.000% 9/0 | $221,666,000 | -9.8% | 163,385,000 | 0.0% | 3.94% | -23.8% | ||
| CMAX | New | CAREMAX INC | $216,446,000 | – | 16,778,750 | +100.0% | 3.84% | – |
| AHCO | Buy | ADAPTHEALTH CORP | $201,567,000 | +140.7% | 7,353,792 | +222.8% | 3.58% | +103.4% |
| Buy | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $156,612,000 | +1.4% | 157,390,000 | +5.2% | 2.78% | -14.3% | |
| New | GLAUKOS CORPnote 2.750% 6/1 | $153,534,000 | – | 90,000,000 | +100.0% | 2.73% | – | |
| New | NATERA INCnote 2.250% 5/0 | $136,309,000 | – | 45,000,000 | +100.0% | 2.42% | – | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $131,241,000 | -0.5% | 80,000,000 | 0.0% | 2.33% | -15.9% | ||
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $120,032,000 | +119.9% | 7,222,127 | +141.1% | 2.13% | +85.9% |
| New | ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $112,018,000 | – | 52,500,000 | +100.0% | 1.99% | – | |
| New | NUVASIVE INCnote 1.000% 6/0 | $101,298,000 | – | 96,966,000 | +100.0% | 1.80% | – | |
| EWTX | EDGEWISE THERAPEUTICS INC | $83,894,000 | -34.4% | 3,933,137 | 0.0% | 1.49% | -44.5% | |
| LUNG | Buy | PULMONX CORP | $79,455,000 | +85.4% | 1,800,887 | +92.2% | 1.41% | +56.6% |
| INSULET CORPnote 0.375% 9/0 | $78,182,000 | +2.7% | 57,581,000 | 0.0% | 1.39% | -13.2% | ||
| Buy | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $77,769,000 | +154.4% | 41,825,000 | +91.6% | 1.38% | +114.8% | |
| AFIB | ACUTUS MED INC | $73,724,000 | +27.0% | 4,341,799 | 0.0% | 1.31% | +7.4% | |
| CNC | Sell | CENTENE CORP DEL | $72,565,000 | -42.8% | 995,000 | -49.9% | 1.29% | -51.7% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $70,557,000 | +0.1% | 725,000 | 0.0% | 1.25% | -15.5% | |
| PCRX | Sell | PACIRA BIOSCIENCES INC | $69,600,000 | -14.8% | 1,147,000 | -1.5% | 1.24% | -28.0% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $61,162,000 | +87.6% | 1,362,790 | +8.3% | 1.09% | +58.5% |
| MIRM | MIRUM PHARMACEUTICALS INC | $59,632,000 | -12.8% | 3,448,912 | 0.0% | 1.06% | -26.3% | |
| MOH | MOLINA HEALTHCARE INC | $58,653,000 | +8.3% | 231,776 | 0.0% | 1.04% | -8.5% | |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $57,253,000 | -23.8% | 5,830,249 | +13.3% | 1.02% | -35.6% |
| New | INSMED INCnote 0.750% 6/0 | $55,522,000 | – | 50,000,000 | +100.0% | 0.99% | – | |
| SILK | Buy | SILK RD MED INC | $54,490,000 | +120.2% | 1,138,525 | +133.0% | 0.97% | +86.2% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $54,357,000 | -4.9% | 338,000 | -5.3% | 0.97% | -19.6% |
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $54,128,000 | +35.4% | 1,601,427 | -6.3% | 0.96% | +14.4% |
| Sell | INSMED INCnote 1.750% 1/1 | $52,525,000 | -22.7% | 50,000,000 | -18.0% | 0.93% | -34.7% | |
| QDEL | New | QUIDEL CORP | $52,429,000 | – | 409,219 | +100.0% | 0.93% | – |
| ATEC | Buy | ALPHATEC HLDGS INC | $52,125,000 | +3.1% | 3,402,384 | +6.3% | 0.93% | -12.9% |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $51,920,000 | +9.2% | 57,791,000 | 0.0% | 0.92% | -7.7% | ||
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $51,839,000 | +97.8% | 2,163,554 | +112.1% | 0.92% | +67.2% |
| DFPH | Sell | DFP HEALTHCARE ACQUISITNS CO | $49,750,000 | -52.2% | 5,000,000 | -52.2% | 0.88% | -59.6% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $49,696,000 | -24.6% | 1,565,712 | +9.0% | 0.88% | -36.2% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $49,188,000 | +107.5% | 1,343,560 | +154.2% | 0.87% | +75.5% |
| CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $47,809,000 | +3.2% | 49,064,000 | 0.0% | 0.85% | -12.8% | ||
| SWTX | SPRINGWORKS THERAPEUTICS INC | $46,032,000 | +12.0% | 558,574 | 0.0% | 0.82% | -5.3% | |
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $45,640,000 | +2.1% | 45,000,000 | 0.0% | 0.81% | -13.7% | ||
| GLPG | New | GALAPAGOS NVspon adr | $45,261,000 | – | 657,005 | +100.0% | 0.80% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $44,821,000 | +69.2% | 2,835,000 | +8.8% | 0.80% | +42.9% |
| NOVAVAX INCnote 3.750% 2/0 | $44,647,000 | +8.8% | 25,000,000 | 0.0% | 0.79% | -8.1% | ||
| HOWL | New | WEREWOLF THERAPEUTICS INC | $44,521,000 | – | 2,552,787 | +100.0% | 0.79% | – |
| APR | Buy | APRIA INC | $44,041,000 | +31.4% | 1,572,892 | +31.1% | 0.78% | +11.1% |
| ONCR | ONCORUS INC | $43,456,000 | -0.9% | 3,148,977 | 0.0% | 0.77% | -16.2% | |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $42,459,000 | +1.4% | 300,000 | -28.6% | 0.75% | -14.3% |
| OMI | Sell | OWENS & MINOR INC NEW | $42,182,000 | -27.6% | 996,500 | -35.7% | 0.75% | -38.8% |
| NUVASIVE INCnote 0.375% 3/1 | $39,639,000 | -3.0% | 40,000,000 | 0.0% | 0.70% | -18.0% | ||
| RYTM | RHYTHM PHARMACEUTICALS INC | $38,957,000 | -7.9% | 1,989,625 | 0.0% | 0.69% | -22.2% | |
| KURA | New | KURA ONCOLOGY INC | $37,405,000 | – | 1,794,000 | +100.0% | 0.66% | – |
| INZY | Buy | INOZYME PHARMA INC | $37,130,000 | -4.5% | 2,178,985 | +10.9% | 0.66% | -19.2% |
| ISEE | IVERIC BIO INC | $36,392,000 | +2.1% | 5,767,409 | 0.0% | 0.65% | -13.8% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $34,607,000 | -5.6% | 3,769,795 | 0.0% | 0.62% | -20.1% | |
| BDSI | BIODELIVERY SCIENCES INTL IN | $34,117,000 | -8.4% | 9,530,000 | 0.0% | 0.61% | -22.6% | |
| NUVB | Buy | NUVATION BIO INC | $33,304,000 | +6.2% | 3,577,233 | +19.2% | 0.59% | -10.2% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $32,162,000 | +63.7% | 4,829,069 | +37.9% | 0.57% | +38.3% |
| VIVO | Buy | MERIDIAN BIOSCIENCE INC | $31,590,000 | +35.3% | 1,424,274 | +60.2% | 0.56% | +14.3% |
| ORTX | ORCHARD THERAPEUTICS PLCads | $30,508,000 | -39.5% | 6,949,416 | 0.0% | 0.54% | -48.9% | |
| ARDX | Buy | ARDELYX INC | $28,892,000 | +70.4% | 3,811,554 | +48.8% | 0.51% | +44.1% |
| New | HEALTH CATALYST INCnote 2.500% 4/1 | $28,740,000 | – | 15,000,000 | +100.0% | 0.51% | – | |
| TERN | TERNS PHARMACEUTICALS INC | $28,761,000 | -44.3% | 2,345,959 | 0.0% | 0.51% | -52.9% | |
| GRAY | GRAYBUG VISION INC | $28,680,000 | -2.2% | 5,281,713 | 0.0% | 0.51% | -17.4% | |
| XERIS PHARMACEUTICALS INCnote 5.000% 7/1 | $28,545,000 | -6.2% | 18,000,000 | 0.0% | 0.51% | -20.7% | ||
| FOLD | Buy | AMICUS THERAPEUTICS INC | $28,356,000 | +6.4% | 2,941,492 | +9.0% | 0.50% | -10.0% |
| ITMR | ITAMAR MED LTDsponsored ads | $28,114,000 | -1.7% | 1,193,803 | 0.0% | 0.50% | -17.0% | |
| GRPH | New | GRAPHITE BIO INC | $27,851,000 | – | 906,308 | +100.0% | 0.50% | – |
| XLRN | ACCELERON PHARMA INC | $27,545,000 | -7.5% | 219,500 | 0.0% | 0.49% | -21.9% | |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $27,465,000 | +97.1% | 804,000 | +89.8% | 0.49% | +66.6% |
| CGEM | New | CULLINAN ONCOLOGY INC | $26,883,000 | – | 1,044,000 | +100.0% | 0.48% | – |
| XERS | XERIS PHARMACEUTICALS INC | $26,672,000 | -9.8% | 6,553,398 | 0.0% | 0.47% | -23.7% | |
| FATE | FATE THERAPEUTICS INC | $26,384,000 | +5.3% | 304,000 | 0.0% | 0.47% | -11.0% | |
| BKD | Sell | BROOKDALE SR LIVING INC | $26,054,000 | -42.5% | 3,298,000 | -56.0% | 0.46% | -51.4% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $24,783,000 | +22.0% | 281,754 | +34.8% | 0.44% | +3.0% |
| AVAH | New | AVEANNA HEALTHCARE HLDGS INC | $24,740,000 | – | 2,000,000 | +100.0% | 0.44% | – |
| CYTK | Sell | CYTOKINETICS INC | $24,502,000 | -58.9% | 1,238,083 | -51.7% | 0.44% | -65.3% |
| BHG | New | BRIGHT HEALTH GROUP INC | $24,024,000 | – | 1,400,000 | +100.0% | 0.43% | – |
| KNTE | Buy | KINNATE BIOPHARMA INC | $23,746,000 | +120.9% | 1,020,000 | +195.7% | 0.42% | +86.7% |
| SPRB | New | SPRUCE BIOSCIENCES INC | $22,946,000 | – | 2,046,958 | +100.0% | 0.41% | – |
| ALEC | ALECTOR INC | $21,980,000 | +3.4% | 1,055,192 | 0.0% | 0.39% | -12.8% | |
| TIL | INSTIL BIO INC | $21,556,000 | -23.0% | 1,115,739 | 0.0% | 0.38% | -34.9% | |
| MAACU | New | MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025 | $21,320,000 | – | 2,000,000 | +100.0% | 0.38% | – |
| PROF | PROFOUND MED CORP | $21,232,000 | -18.8% | 1,297,797 | 0.0% | 0.38% | -31.3% | |
| NEVRO CORPnote 2.750% 4/0 | $20,863,000 | +14.6% | 12,000,000 | 0.0% | 0.37% | -3.1% | ||
| OM | New | OUTSET MED INC | $20,023,000 | – | 400,622 | +100.0% | 0.36% | – |
| PHVS | PHARVARIS N V | $19,240,000 | -33.4% | 1,032,757 | 0.0% | 0.34% | -43.7% | |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $18,648,000 | – | 818,980 | +100.0% | 0.33% | – |
| STXS | New | STEREOTAXIS INC | $17,767,000 | – | 1,843,000 | +100.0% | 0.32% | – |
| JANX | New | JANUX THERAPEUTICS INC | $17,465,000 | – | 700,000 | +100.0% | 0.31% | – |
| QSI | New | QUANTUM SI INC | $17,164,000 | – | 1,400,000 | +100.0% | 0.30% | – |
| DYN | Buy | DYNE THERAPEUTICS INC | $16,558,000 | +55.4% | 787,000 | +14.7% | 0.29% | +31.2% |
| AVTE | New | AEROVATE THERAPEUTICS INC | $16,307,000 | – | 714,285 | +100.0% | 0.29% | – |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $15,558,000 | -6.8% | 14,527,000 | 0.0% | 0.28% | -21.4% | ||
| BLUE | BLUEBIRD BIO INC | $15,360,000 | +6.1% | 480,300 | 0.0% | 0.27% | -10.2% | |
| CMRX | CHIMERIX INC | $14,530,000 | -17.0% | 1,816,221 | 0.0% | 0.26% | -29.9% | |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $14,096,000 | +92.6% | 360,966 | +110.0% | 0.25% | +62.3% |
| MDVL | MEDAVAIL HOLDINGS INC | $13,996,000 | -12.5% | 1,142,552 | 0.0% | 0.25% | -25.9% | |
| RNA | Buy | AVIDITY BIOSCIENCES INC | $13,841,000 | +39.8% | 560,132 | +23.4% | 0.25% | +18.3% |
| BVS | Sell | BIOVENTUS INC | $13,703,000 | -6.3% | 778,567 | -18.6% | 0.24% | -20.8% |
| PRVA | New | PRIVIA HEALTH GROUP INC | $13,311,000 | – | 300,000 | +100.0% | 0.24% | – |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $13,223,000 | +49.7% | 825,937 | +67.1% | 0.24% | +26.3% |
| ANNX | ANNEXON INC | $13,144,000 | -19.1% | 583,913 | 0.0% | 0.23% | -31.9% | |
| COGT | Buy | COGENT BIOSCIENCES INC | $12,984,000 | +47.9% | 1,601,000 | +60.1% | 0.23% | +24.9% |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $12,770,000 | -49.8% | 1,047,599 | 0.0% | 0.23% | -57.5% | |
| CNVY | New | CONVEY HLDG PARENT INC | $12,518,000 | – | 1,100,000 | +100.0% | 0.22% | – |
| AMWL | AMERICAN WELL CORPcl a | $12,468,000 | -27.6% | 991,115 | 0.0% | 0.22% | -39.0% | |
| AGL | New | AGILON HEALTH INC | $12,171,000 | – | 300,000 | +100.0% | 0.22% | – |
| GHRS | New | GH RESEARCH PLCordinary shares | $12,069,000 | – | 555,416 | +100.0% | 0.21% | – |
| CVRX | New | CVRX INC | $11,200,000 | – | 400,000 | +100.0% | 0.20% | – |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $11,144,000 | – | 400,000 | +100.0% | 0.20% | – |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $10,420,000 | -3.8% | 1,000,000 | 0.0% | 0.18% | -18.9% | |
| BCAB | Buy | BIOATLA INC | $10,399,000 | -0.4% | 245,381 | +19.5% | 0.18% | -15.5% |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $10,200,000 | +1.9% | 1,000,000 | 0.0% | 0.18% | -13.8% | |
| SNRHU | SENIOR CONNECT ACQUISITN CORunit 12/09/2023 | $10,120,000 | +1.1% | 1,000,000 | 0.0% | 0.18% | -14.3% | |
| REVHU | REVOLUTION HEALTHCAR AQ CORPunit 03/18/20266 | $10,080,000 | +0.3% | 1,000,000 | 0.0% | 0.18% | -15.2% | |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $10,020,000 | -0.3% | 1,000,000 | 0.0% | 0.18% | -15.6% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $9,895,000 | -58.3% | 2,827,000 | +17.6% | 0.18% | -64.7% |
| CMIIU | CM LIFE SCIENCES II INCunit 02/25/2028 | $8,070,000 | +5.1% | 600,000 | 0.0% | 0.14% | -11.2% | |
| RPHM | New | RENEO PHARMACEUTICALS INC | $7,924,000 | – | 849,300 | +100.0% | 0.14% | – |
| GLUE | New | MONTE ROSA THERAPEUTICS INC | $7,945,000 | – | 350,000 | +100.0% | 0.14% | – |
| OLMA | OLEMA PHARMACEUTICALS INC | $7,588,000 | -15.7% | 271,191 | 0.0% | 0.14% | -28.6% | |
| TMPMU | TURMERIC ACQUISITION CORPunit 10/08/2025 | $7,545,000 | +0.6% | 750,000 | 0.0% | 0.13% | -15.2% | |
| IGNYU | IGNYTE ACQUISITION CORPunit 01/05/2026 | $7,265,000 | 0.0% | 725,000 | 0.0% | 0.13% | -15.7% | |
| TPTX | TURNING POINT THERAPEUTICS I | $6,542,000 | -17.5% | 83,846 | 0.0% | 0.12% | -30.5% | |
| DCTH | DELCATH SYS INC | $6,305,000 | +1.5% | 500,000 | 0.0% | 0.11% | -14.5% | |
| TALK | New | TALKSPACE INC | $6,233,000 | – | 750,000 | +100.0% | 0.11% | – |
| BENEFITFOCUS INCnote 1.250%12/1 | $6,130,000 | +3.3% | 6,500,000 | 0.0% | 0.11% | -12.8% | ||
| INSM | New | INSMED INC | $5,692,000 | – | 200,000 | +100.0% | 0.10% | – |
| CHFWU | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $5,200,000 | +6.6% | 500,000 | 0.0% | 0.09% | -10.7% | |
| OHPAU | ORION ACQUISITION CORPunit 02/19/2026 | $4,960,000 | -0.8% | 500,000 | 0.0% | 0.09% | -16.2% | |
| XENT | INTERSECT ENT INC | $4,366,000 | -18.1% | 255,456 | 0.0% | 0.08% | -30.4% | |
| CABA | CABALETTA BIO INC | $3,993,000 | -22.5% | 464,252 | 0.0% | 0.07% | -34.3% | |
| BMEA | New | BIOMEA FUSION INC | $3,878,000 | – | 248,447 | +100.0% | 0.07% | – |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $3,542,000 | -25.1% | 733,333 | 0.0% | 0.06% | -36.4% | |
| CMAXW | New | CAREMAX INC*w exp 06/08/202 | $3,172,000 | – | 672,000 | +100.0% | 0.06% | – |
| ACHL | Sell | ACHILLES THERAPEUTICS PLCsponsored ads | $2,951,000 | -77.7% | 301,431 | -62.3% | 0.05% | -81.3% |
| NEOGENOMICS INCnote 0.250% 1/1 | $2,452,000 | -2.9% | 2,500,000 | 0.0% | 0.04% | -17.0% | ||
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $2,398,000 | +234.0% | 166,666 | 0.0% | 0.04% | +186.7% | |
| DFPHW | DFP HEALTHCARE ACQUISITNS CO*w exp 03/31/202 | $2,163,000 | +28.1% | 1,250,000 | 0.0% | 0.04% | +8.6% | |
| QSIAW | New | QUANTUM SI INC*w exp 06/10/202 | $1,253,000 | – | 333,333 | +100.0% | 0.02% | – |
| MTCR | METACRINE INC | $1,054,000 | -38.7% | 277,469 | 0.0% | 0.02% | -47.2% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $433,000 | -2.7% | 166,666 | 0.0% | 0.01% | -11.1% | |
| LUMO | Sell | LUMOS PHARMA INC | $331,000 | -92.4% | 33,117 | -91.1% | 0.01% | -93.5% |
| WINT | WINDTREE THERAPEUTICS INC | $46,000 | -6.1% | 20,148 | 0.0% | 0.00% | 0.0% | |
| IMRA | Exit | IMARA INC | $0 | – | -79,465 | -100.0% | -0.01% | – |
| DFHTW | Exit | DEERFIELD HEALTHCARE TECH AC*w exp 07/16/202 | $0 | – | -672,000 | -100.0% | -0.03% | – |
| LABP | Exit | LANDOS BIOPHARMA INC | $0 | – | -450,000 | -100.0% | -0.09% | – |
| SNSE | Exit | SENSEI BIOTHERAPEUTICS INC | $0 | – | -375,000 | -100.0% | -0.12% | – |
| GRCL | Exit | GRACELL BIOTECHNOLOGIES INCsponsored ads | $0 | – | -400,000 | -100.0% | -0.13% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -150,000 | -100.0% | -0.14% | – |
| INNV | Exit | INNOVAGE HLDG CORP | $0 | – | -300,000 | -100.0% | -0.16% | – |
| WOOF | Exit | PETCO HEALTH & WELLNESS CO I | $0 | – | -500,000 | -100.0% | -0.23% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -919,000 | -100.0% | -0.24% | – |
| BOLT | Exit | BOLT BIOTHERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.24% | – |
| SGFY | Exit | SIGNIFY HEALTH INC | $0 | – | -400,000 | -100.0% | -0.25% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -2,142,857 | -100.0% | -0.26% | – |
| CAPAU | Exit | HIGHCAPE CAP ACQUISITION CORunit 09/30/2027 | $0 | – | -1,000,000 | -100.0% | -0.27% | – |
| SYK | Exit | STRYKER CORPORATION | $0 | – | -59,000 | -100.0% | -0.30% | – |
| RUBY | Exit | RUBIUS THERAPEUTICS INC | $0 | – | -550,000 | -100.0% | -0.31% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -468,000 | -100.0% | -0.33% | – |
| CERT | Exit | CERTARA INC | $0 | – | -600,000 | -100.0% | -0.34% | – |
| MAACU | Exit | MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025 | $0 | – | -2,000,000 | -100.0% | -0.43% | – |
| GBIO | Exit | GENERATION BIO CO | $0 | – | -897,779 | -100.0% | -0.54% | – |
| SHC | Exit | SOTERA HEALTH CO | $0 | – | -1,111,000 | -100.0% | -0.58% | – |
| HRC | Exit | HILL ROM HLDGS INC | $0 | – | -279,870 | -100.0% | -0.65% | – |
| OCDX | Exit | ORTHO CLINICAL DIAGNOSTICS H | $0 | – | -2,352,941 | -100.0% | -0.95% | – |
| DFHT | Exit | DEERFIELD HEALTHCARE TECH AC | $0 | – | -6,778,750 | -100.0% | -1.73% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -310,000 | -100.0% | -1.82% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -579,248 | -100.0% | -1.86% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -2,857,000 | -100.0% | -2.32% | – |
| Exit | NEVRO CORPnote 1.750% 6/0 | $0 | – | -115,776,000 | -100.0% | -3.54% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.